[PDF][PDF] Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
RJ Packer, A Gajjar, G Vezina… - Journal of clinical …, 2006 - academia.edu
RJ Packer, A Gajjar, G Vezina, L Rorke-Adams, PC Burger, PL Robertson, L Bayer…
Journal of clinical oncology, 2006•academia.eduPhase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for
Newly Diagnosed Average-Risk Medulloblas Page 1 Phase III Study of Craniospinal Radiation
Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk
Medulloblastoma Roger J. Packer, Amar Gajjar, Gilbert Vezina, Lucy Rorke-Adams, Peter C.
Burger, Patricia L. Robertson, Lisa Bayer, Deborah LaFond, Bernadine R. Donahue, MaryAnne
H. Marymont, Karin Muraszko, James Langston, and Richard Sposto A B S T R A C T Purpose …
Newly Diagnosed Average-Risk Medulloblas Page 1 Phase III Study of Craniospinal Radiation
Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk
Medulloblastoma Roger J. Packer, Amar Gajjar, Gilbert Vezina, Lucy Rorke-Adams, Peter C.
Burger, Patricia L. Robertson, Lisa Bayer, Deborah LaFond, Bernadine R. Donahue, MaryAnne
H. Marymont, Karin Muraszko, James Langston, and Richard Sposto A B S T R A C T Purpose …
Purpose
To determine the event-free survival (EFS) and overall survival of children with average-risk medulloblastoma and treated with reduced-dose craniospinal radiotherapy (CSRT) and one of two postradiotherapy chemotherapies.
academia.edu
